Scope
Reference
C369873
Description
Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping
Contract 1. Blood Group Genotyping for Sickle Cell and Thalassaemia
Supplier
Contract value
- £140,671 excluding VAT
- £168,805.20 including VAT
Above the relevant threshold
Earliest date the contract will be signed
5 December 2025
Contract dates (estimated)
- 8 December 2025 to 31 March 2026
- 3 months, 24 days
Main procurement category
Services
CPV classifications
- 85100000 - Health services
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Single supplier - technical reasons
Due to an absence of competition for technical reasons. Para 6, Schedule 5 of PA 2023 utilised.
NHSBT have been verified as the only organisation in England that could deliver this service for the planned typing of patients with Sickle Cell Disease blood patients, thalassemia and rare inherited anaemia
Supplier
NHSBT
- NHS Organisation Data Service: T1460
500 North Bristol Park, Filton
Bristol
BS34 7QH
United Kingdom
Telephone: +44 7764280366
Email: customer.services@nhsbt.nhs.uk
Website: http://www.cromalocksmiths.com
Region: UKK12 - Bath and North East Somerset, North Somerset and South Gloucestershire
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Contract 1. Blood Group Genotyping for Sickle Cell and Thalassaemia
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: england.commercialqueries@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government